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Abstract
The COVID-19 pandemic brought living donor kidney transplant programs across the
United States to a near halt in March 2020. As programs have begun to reopen, potential donor candidates often inquire about their risk of a COVID-19 infection and
its potential impact on kidney function after donation. To address their concerns, we
surveyed 1740 former live kidney donors at four transplant centers located in New
York and Michigan. Of these, 839 (48.2%) donors responded, their mean age was
46 ± 12.5 years, 543 (65%) were females, and 611 (73%) were white. Ninety-two
donors (11%) had symptoms suggestive of a COVID-19 infection with fever (48%)
and fatigue (43%) being the most common. Among those with symptoms, 42 donors
underwent testing and 16 tested positive. Testing was more common among donors
with private insurance, and a positive test result was more common among young
black donors. Only one donor surveyed required hospitalization and none required
dialysis. Fourteen donors have recovered completely and two partially. Our survey
highlights that a COVID-19 infection in former donors results in a mild disease with
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programs were fully suspended. 2,3 The LDKT is considered an
“elective procedure” and was postponed to conserve hospital

Coronavirus disease 19 (COVID-19), caused by the novel SARS-

resources and also to protect the recipient and the donor from

CoV-2 , was declared a national emergency on March 13, 2020.1

COVID-19 infection. 3 As the initial surge of COVID-
19 infec-

This declaration led to an abrupt halt to the living donor kidney

tions subsided and the hospital resource have been replenished,

transplant (LDKT) surgery in most parts of the United States.

elective surgeries including LDKTs have resumed. Living donor

During the week of March 24, 2020, over two-t hirds of the LDKT

safety is of paramount importance for all programs. The American
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Society of Transplantation and American Society of Transplant

2.3 | Survey administration

Surgeons have put forth recommendations to guide programs to
safely resume LDKT.4,5 The recommendations include testing and

Columbia, Cornell and the University of Michigan sent the survey

self-quarantining to ensure that neither the donor nor the recip-

to donors with a known email address through the Qualtrics Survey

ient has asymptomatic COVID-19 infection at the time of trans-

Software. The message in the email gave donors an option to opt

plant surgery. However, currently there is no guidance available

out and, by answering the survey questions the donor consented

on how potential donors should be counseled on their future risk

to participate in the study. Two additional weekly reminders were

of infection with COVID-19 and its potential implications on their

sent to the non-respondents. Henry Ford Hospital contacted their

renal function after donor nephrectomy. Not surprisingly, these

donors weekly, up to three times, to conduct the survey over the

questions are being raised by prospective donors especially given

phone. All donors were given an option to opt out of the study at

the evidence of risk among individuals with reduced kidney func-

the time of the phone call. Donors were surveyed or contacted from

tion. 6-9 The living donor evaluation includes extensive medical

June 5 through August 31, 2020. Each transplant center contacted

testing prior to donation resulting in a donor pool with relatively

the United Network for Organ Sharing (UNOS) to obtain informa-

few comorbidities, if any, and therefore, former donors should

tion on death and/or need for chronic dialysis on the living donors

not be at higher risk for severe infection than general population.

included in the study during the pandemic (March 1, 2020, through

However, there are no data to support such counseling. As a result,

October 1, 2020).

we surveyed prior donors who had underwent donor nephrectomy at four transplant centers located in the epicenters during
early stages of the COVID-19 pandemic: New York and Michigan.

2.4 | Statistical analysis

Herein, we report the responses of former donors as it relates to
COVID-19 infection, testing, and recovery.

Responses to each survey question were described as percentages
or means, as appropriate. To obtain percentages, we divided the

2
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2.1 | Study participants and setting

number of “yes” responses by the total number of participants who
responded to the question. For questions about symptoms where
participants were asked to “select all that apply,” the presenting clinical feature was reported as percentages of donors with that symptom. Donors were divided into four groups based on symptoms and

All living kidney donors who donated between January 1, 2015, to

testing results (if taken): (a) asymptomatic, (b) symptomatic but did

March 31, 2020, at 4 transplant centers were contacted to inquire if

not undergo testing, (c) symptomatic with negative COVID-19 test-

they had contracted a COVID-19 infection. The participating trans-

ing, and (d) symptomatic with positive COVID-19 testing. The dif-

plant centers were located in New York—Columbia University Irving

ferences in baseline demographics and responses between the four

Medical Center and Weill Cornell Medicine and Michigan—Henry

groups were assessed using ANOVA, chi-square test, and Fisher

Ford Hospital and University of Michigan Hospital. All donors with

exact tests as appropriate. All analyses were performed using SAS

an available email address were contacted except those from Henry

for windows version 9.4 (SAS Institute).

Ford Hospital who were contacted via phone instead (due to lack of
email address). The protocol was approved by the local institutional
regulatory board at each site.

3

2.2 | Survey design

plant centers between January 1 2015, through March 31, 2020. Of

|

R E S U LT S

We contacted 1740 live kidney donors who donated at the four transthese, 841 donors responded and 2 opted out. The study consisted

The survey instrument developed by the study investigators

of 839 donors (Figure 1). The response rate varied at participating

assessed key topics of interest and consisted of 17 questions

transplant centers and was as follows: Weill Cornell Medicine—348

(Appendix S1). Participants were asked if they developed symp-

out of 654 (45%), University of Michigan—190 out of 345 (55%),

toms suggestive of COVID-19 infection (fever, sore throat, diar-

Columbia University Irving Medical Center—184 out of 489 (38%),

rhea, fatigue, loss of taste or smell), with additional follow-up

and Henry Ford Hospital—114 out of 252 (45%). The mean of age

questions including when symptoms developed, whether the in-

of donors who were included in the study was 46 ± 12.5 years, 543

fection was confirmed via a nose or throat swab, when the test

(65%) were females, 611 (73%) were white, 76 (9%) were blacks, 69

was performed, how they got infected, if they were hospitalized

(8%) had hypertension, and 261 (31%) had donated between 2019

and whether the infection affected their kidney function or if they

and 2020.

needed dialysis, and lastly if they have recovered from COVID-19

Of the 839 donors who completed the survey or were successfully

infection. We also collected information on their education level,

contacted, 92 (11%) developed symptoms suggestive of a COVID-19

medical insurance, and work status.

infection. The symptoms and their frequency were fever (48%), fatigue

|
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F I G U R E 1 Distribution of the study
participants based on symptoms and
testing for COVID-19 and recovery after
infection

Study parcipants

3 of 5

839 agreed to parcipate
92 had symptoms
suggesve of COVID19 infecon

Symptoms of COVID-19

50 did not
get tested

Tesng for COVID-19

747
asymptomac

42 got
tested

26 tested
negave

16 tested
posive
14 recovered fully
2 parally

TA B L E 1 Comparison of characteristics
among donors grouped by symptoms of a
COVID-19 infection and testing results

Asymptomatic

Symptomatic for a COVID-19 infection

Not tested

Not tested

Tested

(n = 747)

(n = 50)

Positive
(n = 16)

Negative
(n = 26)

Age, years

47 ± 13

41 ± 12

42 ± 13

45 ± 14

.01

Female gender (%)

488 (65%)

25 (50%)

11 (69%)

19 (73%)

.13

546 (73%)

39 (78%)

8 (50%)

18(69%)

.04

65 (9%)

4 (8%)

4 (25%)

3 (12%)

136 (18%)

7 (14%)

4 (25%)

5 (19%)

p-Value

Race
White
Black
Others
Education
Some HS
HS

10 (1%)

0

0

0

79 (11%)

4 (8%)

3 (18%)

0

Some College

137 (18%)

11 (22%)

2 (13%)

4 (15%)

College

230 (31%)

22 (44%)

4 (25%)

9 (35%)

Graduate/
Professional

282 (38%)

10 (20%)

7 (44%)

12 (46%)

9 (1%)

3 (6%)

Missing

0

1 (4%)

0

1 (4%)

.29

Insurance
None

35 (5%)

3 (6%)

Medicaid

42 (6%)

10 (20%)

2 (13%)

Medicare

.02

0

80 (11%)

4(8%)

2 (12%)

3 (12%)

Private

590 (78%)

33 (66%)

12 (75%)

22 (84%)

Working, yes

532 (71%)

35 (70%)

11 (69%)

20 (77%)

.80

63 (8%)

3(6%)

1 (6%)

2(8%)

.93

100 (13%)

7 (14%)

3 (19%)

1 (4%)

.74

2016

114 (15%)

13 (26%)

3 (19%)

3 (11%)

2017

120 (16%)

7 (14%)

3 (19%)

5 (19%)

2018

176 (24%)

10 (20%)

5 (31%)

8 (31%)

2019

183 (25%)

11 (22%)

2 (12%)

8 (31%)

2020

54 (7%)

2 (4%)

HTN, yes
Year of donation
2015

0

1 (4%)

Note: Data are presented as mean ± standard deviation & number of patients (%).
Abbreviations: HS, high school; HTN, history of hypertension.
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(43%), sore throat (34%), shortness of breath (32%), loss of smell or

black and young donors were more likely to develop COVID-19 in-

taste (25%), and diarrhea (16%). Most of the donors developed symp-

fection.11,12 This could be related to socio-economic factors lead-

toms in March and April (59 out of 92, 64%). The proportion of donors

ing to limited ability to engage in physical distancing and access to

developing symptoms was similar across all four transplant centers

health care. There was no difference in the proportion of donors

ranging from 9% to 13% and did not vary by the year of donation.

working through the pandemic and development of COVID-19 in-

Of the 92 donors with symptoms, 42 (46%) got tested for
COVID-19 infection via a nasal or throat swab—among whom 16

fection or symptoms. It is possible that younger donors would have
contracted the virus from community.

tested positive. Of the 16 donors who tested positive, 10 tested

The strengths of our study are the good response rate of 48%,

positive in March and April (N = 10 out of 16, 62.5%). Table 1 com-

the sampling of the population from transplant centers with large

pares demographic characteristics of donors across 4 groups (a)

living donor volumes located in the epicenter of the pandemic and

asymptomatic, (b) symptomatic but did not undergo testing, (c)

our ability to ascertain outcomes in non-respondents from UNOS/

symptomatic with negative COVID-19 testing, and (d) symptomatic

OPTN data. The proportion of donors with symptoms suggestive

with positive COVID-19 testing. Donors who developed COVID-19

of a COVID-19 infection and those with confirmed infection were

symptoms were more likely to be young. Testing for a COVID-19

similar across all transplant centers and therefore is reflective of

infection was more common among donors with private insurance

entire study population and not skewed by any particular center.

(81% vs 66%; p = .02). Young black donors were more likely to have

Limitations of our study are that not every donor with symptoms

a confirmed COVID-19 infection. Approximately half of the donors

was tested and the donors who did not respond to our survey were

(50%) were unaware of how they contracted the virus (8 out of 16).

more likely to be younger black males, and both could lead to our

The percentage of donors with a confirmed COVID-19 infection was

underreporting of the prevalence COVID-19 infection in former live

also similar across all four transplant centers and ranged from 1% to

kidney donors. We do not have access to actual test reports and

3% and also by the year of donation.

therefore rely on the accuracy of self-reporting, particularly as it

Out of the 57 donors who underwent nephrectomy in 2020,

relates to the impact on renal function. Since most of our donors

three reported developing symptoms suggestive of a COVID-19 in-

were managed at home and had mild disease, we believe that acute

fection. None of them had symptoms at their 1 month post-donation

kidney injury is less likely to occur in this population. Lastly, our re-

visit. Among the donors with symptoms of a COVID-19 infection and

sults could be affected by recall bias but the donors were queried

those who tested positive, only one donor required hospitalization

within 6 months of onset of the pandemic. Give the public aware-

and all others were managed at home. None of the donors reported

ness around COVID-19 infection, it would be hard for an individual

deterioration in their kidney function or required dialysis. Fourteen

to forget that they had symptoms or confirmed infection.

donors with confirmed infection have recovered completely, and

In summary, our small study confirms mild COVID-19 infections

two have reported partial recovery. Communications with UNOS

in former living kidney donors with good recovery. Among those

confirms that none of the donors eligible for this study died or ini-

infected, none reported deterioration in their kidney function.

tiated on chronic dialysis during the study period (March 1, 2020,

Findings from this study can be used by the transplant community

through October 1, 2020).

to counsel living donors who are considering kidney donation during
this pandemic. While living donors do not seem to have severe from

4
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DISCUSSION

COVID-19 infection, the decision to continue living donor transplants should be based on institutional policies and local prevalence.

Our study reports that the rate of confirmed COVID-19 infection

AC K N OW L E D G M E N T S

in former living kidney donors is low, 2%. It is possible that the true

This work would not have been possible without the help of the liv-

infection rate may be higher as over half the donors with symptoms

ing donor coordinators at each of the transplant center.

did not get tested (50 out of 92), possibly due to the lack of availability of universal testing early during the pandemic and lack of pri-

C O N FL I C T O F I N T E R E S T

vate insurance. Similar to the general population, fever was the most

None.

common presenting feature and diarrhea was less common.10 Most
of the donors with COVID-19 infection were managed at home. No

DATA AVA I L A B I L I T Y S TAT E M E N T

participants reported deterioration in kidney function, and all do-

The data that support the findings of this study are available from

nors have recovered fully or partially. The milder course experienced

the corresponding author upon reasonable request.

by the living donor population may be in part due to the young age,
and minimal comorbidities in the donor population. None of the do-

ORCID

nors who donated in 2020 contracted COVID-19 infection due to
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hospitalization for nephrectomy.
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